These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36863241)

  • 1. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
    Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
    Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
    Bhimani F; Feldman S; Cavalli A; Chen Y; Obaid L; Rachofsky C; Gupta A; Pastoriza J; Johnson K; McEvoy M
    Ann Surg Oncol; 2024 Sep; 31(9):5937-5946. PubMed ID: 38844631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    Young S; Geary A; Zhao X; Kenzik K; Cassidy M; Newman R; Merrill AL
    J Surg Oncol; 2024 Aug; 130(2):204-209. PubMed ID: 38873777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
    Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
    JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate-delayed lymphatic reconstruction after axillary lymph nodes dissection for locally advanced breast cancer-related lymphedema prevention: Report of two cases.
    Brahma B; Yamamoto T; Agdelina C; Adella D; Putri RI; Hanifah W; Sundah VH; Perdana AB; Putra MRA; Taher A; Panigoro SS
    Microsurgery; 2024 Jan; 44(2):e31033. PubMed ID: 36896960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.
    Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM
    Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
    Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
    Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients.
    Poulsen L; Kaur M; Jacobsen AL; Bjarnesen MP; Bjarnesen AP; Klassen AF; Pusic AL; de Vries CEE; Sørensen JA
    Breast Cancer Res Treat; 2022 Jan; 191(1):87-96. PubMed ID: 34643834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
    Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
    Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
    [No Abstract]   [Full Text] [Related]  

  • 16. The quality of life in long-term breast cancer survivors with breast cancer related lymphedema.
    Lopez Penha TR; van Bodegraven J; Winkens B; Heuts EM; Voogd AC; von Meyenfeldt MF
    Acta Chir Belg; 2014; 114(4):239-44. PubMed ID: 26021418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
    Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
    J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
    Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
    Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.